JXR Buys Back 6.30 Million Shares for HKD 13.58 Million; Cumulative Repurchases Hit 82.31 Million Under 2025 Mandate

Bulletin Express05-28 20:23

Jinxin Fertility Group Limited (“JXR”) reported an on-market repurchase of 6.30 million ordinary shares on 28 May 2026. The shares were bought at prices between HKD 2.13 and HKD 2.17, for a total consideration of HKD 13.58 million.

Following the latest transaction, issued share capital remains at 2.71 billion shares, as all repurchased shares are pending cancellation. Repurchased but not yet cancelled shares now total 42.65 million, equivalent to approximately 1.58 % of the current issued share count.

Under the general mandate granted on 26 June 2025, JXR is authorised to buy back up to 274.47 million shares. To date, 82.31 million shares—representing 2.999 % of the company’s issued shares on the mandate date—have been repurchased on the Hong Kong Stock Exchange.

No treasury shares are being held; all repurchased shares are earmarked for cancellation. A moratorium on new share issues or treasury-share disposals is in place until 27 June 2026, in line with exchange regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment